Biogen shareholders approve officer exculpation amendment and elect nine directors at annual meeting

BIOGEN INC.

Certificate of Amendment filed to allow officer exculpation to extent permitted by Delaware law; approved with 103.1M votes for, 16.3M against.
All nine director nominees elected with wide margins; Monish Patolawala received 119.1M votes for, highest count.
Ratification of PwC as independent auditor for FY2024: 123.7M for, 5.3M against.
Advisory vote on executive compensation passed with 114.4M for, 5.1M against.
Adoption of 2024 Omnibus Equity Plan and 2024 Employee Stock Purchase Plan both approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.